Barinthus Biotherapeutics Plc (BRNS)
0.7015
-0.01
(-1.07%)
USD |
NASDAQ |
Dec 24, 16:00
Barinthus Biotherapeutics Total Assets (Quarterly): 109.20M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 43.50M |
| Autolus Therapeutics Plc | 661.95M |
| Tiziana Life Sciences Ltd. | -- |
| Aptorum Group Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.64M |
| Shareholders Equity (Quarterly) | 84.46M |
| Debt to Equity Ratio | 0.137 |
| Current Ratio | 8.037 |
| Net Debt Paydown Yield | 0.39% |